"Arthritis, Rheumatoid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Descriptor ID |
D001172
|
| MeSH Number(s) |
C05.550.114.154 C05.799.114 C17.300.775.099 C20.111.199
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Arthritis, Rheumatoid".
Below are MeSH descriptors whose meaning is more specific than "Arthritis, Rheumatoid".
This graph shows the total number of publications written about "Arthritis, Rheumatoid" by people in this website by year, and whether "Arthritis, Rheumatoid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 1 | 2 |
| 1995 | 1 | 0 | 1 |
| 1996 | 3 | 1 | 4 |
| 1997 | 1 | 2 | 3 |
| 1998 | 0 | 1 | 1 |
| 1999 | 6 | 0 | 6 |
| 2000 | 2 | 0 | 2 |
| 2001 | 3 | 1 | 4 |
| 2002 | 4 | 0 | 4 |
| 2003 | 4 | 1 | 5 |
| 2004 | 5 | 1 | 6 |
| 2005 | 3 | 1 | 4 |
| 2006 | 1 | 2 | 3 |
| 2007 | 3 | 1 | 4 |
| 2008 | 4 | 4 | 8 |
| 2009 | 5 | 3 | 8 |
| 2010 | 6 | 1 | 7 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 2 | 5 |
| 2013 | 5 | 3 | 8 |
| 2014 | 2 | 1 | 3 |
| 2015 | 6 | 0 | 6 |
| 2016 | 5 | 1 | 6 |
| 2017 | 5 | 0 | 5 |
| 2018 | 2 | 0 | 2 |
| 2019 | 5 | 1 | 6 |
| 2020 | 4 | 0 | 4 |
| 2021 | 3 | 1 | 4 |
| 2022 | 5 | 0 | 5 |
| 2023 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arthritis, Rheumatoid" by people in Profiles.
-
JAK inhibitors and black box warnings: what is the future for JAK inhibitors? Expert Rev Clin Immunol. 2023 Jul-Dec; 19(11):1385-1397.
-
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors. Drug Saf. 2023 Nov; 46(11):1049-1071.
-
Anticitrullinated peptide antibody epitope expansion and the HLA DRB1 'shared epitope' are less common in seropositive checkpoint inhibitor-induced inflammatory arthritis than in longstanding rheumatoid arthritis. RMD Open. 2023 Jun; 9(2).
-
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis. Ann Rheum Dis. 2023 07; 82(7):920-926.
-
Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center. Dig Dis Sci. 2023 02; 68(2):385-388.
-
Surgical Outcomes, Trends, and Risk Factors of Distal Triceps Repairs. Hand (N Y). 2023 11; 18(8):1300-1306.
-
Occupational Exposures in Rheumatoid Arthritis-related Airway Disease: A Missing Link? Ann Am Thorac Soc. 2022 06; 19(6):1076-1077.
-
Editorial: response to tofacitinib is associated with high rates of long-term treatment persistence. Aliment Pharmacol Ther. 2022 05; 55(9):1222-1223.
-
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset. Ann Rheum Dis. 2022 08; 81(8):1085-1095.
-
Mortality Trends in Rheumatoid Arthritis: Zooming in on Interstitial Lung Disease. Ann Am Thorac Soc. 2021 12; 18(12):1953-1954.